N Efstathiou1, V Soubasi1, G Koliakos2, G Kyriazis3, D I Zafeiriou4, A Slavakis5, K Kantziou1, T Pozotou6, O Chatzizisi3, V Drosou-Agakidou1. 1. 1 Neonatal Department and NICU, Hippokration General Hospital, Aristotle University of Thessaloniki, Greece. 2. Biochemistry Department, Medical School, Aristotle University of Thessaloniki, Greece. 3. Immunology Laboratory, Pulmonology Department, Papanikolaou General Hospital, Aristotle University of Thessaloniki, Greece. 4. 1 Paediatric Department, Hippokration General Hospital, Aristotle University of Thessaloniki, Greece. 5. Biochemistry Department, Hippokration General Hospital, Greece. 6. Medical school, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Abstract
BACKGROUND: Preclinical data and adult studies have showed an endogenous regeneration process following brain damage that involves mobilization of progenitor cells. This process is not well described in preterm neonates. The present study aims to investigate the mobilization of Circulating Progenitor Cells (CPCs) and their relation to biomarkers of brain injury in preterm neonates. METHODS: This is a prospective cohort study of preterm infants with gestational age (GA) <34 weeks. Serial cranial ultrasounds scans were performed in all neonates. Brain injury was defined by the presence of intraventricular hemorrhage grade III/IV, cystic periventricular leukomalacia or infarct. Peripheral blood samples were collected from all neonates on days(d) 1, 3, 9, 18 and 45 of life for the measurement of levels of CPCs [early and late Endothelial Progenitor Cells (EPCs), Haematopoietic Stem Cells (HSCs) and Very Small Embryonic-Like Stem Cells (VSELs)], Neuron-Specific Enolase (NSE), S100b, Erythropoietin (EPO) and Stromal Cell-Derived Factor-1 (SDF-1) . RESULTS: Ten out of the 23 preterm infants included in the study developed brain injury; the remaining thirteen infants served as controls. In the brain injury group a significant increase of HSCs (d9, d45), early EPCs (d3, d9, d18) and late EPCs (d1, d3, d9, d18, d45) was observed compared to controls. VSELs on d45 were significantly higher in controls. S100b on d1, EPO on d1, SDF-1 on d3 and NSE on d18 were significantly increased in the brain injury group. Moreover, CPCs were significantly related to S100b, NSE, EPO and SDF-1 levels at multiple time points. CONCLUSIONS: The observed pattern of CPCs mobilization and its association with biomarkers following brain injury in preterm neonates indicate the existence of an endogenous brain regeneration process. Enhancement of this process with exogenous progenitor cell transplantation might be a powerful therapeutic strategy to restore brain damage and improve the neurodevelopmental outcome in premature infants. Hippokratia 2015; 19 (2):141-147.
BACKGROUND: Preclinical data and adult studies have showed an endogenous regeneration process following brain damage that involves mobilization of progenitor cells. This process is not well described in preterm neonates. The present study aims to investigate the mobilization of Circulating Progenitor Cells (CPCs) and their relation to biomarkers of brain injury in preterm neonates. METHODS: This is a prospective cohort study of preterm infants with gestational age (GA) <34 weeks. Serial cranial ultrasounds scans were performed in all neonates. Brain injury was defined by the presence of intraventricular hemorrhage grade III/IV, cystic periventricular leukomalacia or infarct. Peripheral blood samples were collected from all neonates on days(d) 1, 3, 9, 18 and 45 of life for the measurement of levels of CPCs [early and late Endothelial Progenitor Cells (EPCs), Haematopoietic Stem Cells (HSCs) and Very Small Embryonic-Like Stem Cells (VSELs)], Neuron-Specific Enolase (NSE), S100b, Erythropoietin (EPO) and Stromal Cell-Derived Factor-1 (SDF-1) . RESULTS: Ten out of the 23 preterm infants included in the study developed brain injury; the remaining thirteen infants served as controls. In the brain injury group a significant increase of HSCs (d9, d45), early EPCs (d3, d9, d18) and late EPCs (d1, d3, d9, d18, d45) was observed compared to controls. VSELs on d45 were significantly higher in controls. S100b on d1, EPO on d1, SDF-1 on d3 and NSE on d18 were significantly increased in the brain injury group. Moreover, CPCs were significantly related to S100b, NSE, EPO and SDF-1 levels at multiple time points. CONCLUSIONS: The observed pattern of CPCs mobilization and its association with biomarkers following brain injury in preterm neonates indicate the existence of an endogenous brain regeneration process. Enhancement of this process with exogenous progenitor cell transplantation might be a powerful therapeutic strategy to restore brain damage and improve the neurodevelopmental outcome in premature infants. Hippokratia 2015; 19 (2):141-147.
Authors: Giulia Paviotti; Gian Paolo Fadini; Elisa Boscaro; Carlo Agostini; Angelo Avogaro; Lino Chiandetti; Eugenio Baraldi; Marco Filippone Journal: Early Hum Dev Date: 2011-04-20 Impact factor: 2.079
Authors: Lisa Ayers; Malcolm Kohler; Paul Harrison; Ian Sargent; Rebecca Dragovic; Marianne Schaap; Rienk Nieuwland; Susan A Brooks; Berne Ferry Journal: Thromb Res Date: 2011-01-22 Impact factor: 3.944
Authors: T Asahara; T Murohara; A Sullivan; M Silver; R van der Zee; T Li; B Witzenbichler; G Schatteman; J M Isner Journal: Science Date: 1997-02-14 Impact factor: 47.728
Authors: K Sarafidis; N Efstathiou; O Begou; V Soubasi; E Agakidou; E Gika; G Theodoridis; V Drossou Journal: Hippokratia Date: 2017 Apr-Jun Impact factor: 0.471
Authors: Zhuxiao Ren; Xu Fang; Qi Zhang; Y G Mai; X Y Tang; Q Q Wang; C H Lai; W H Mo; Y H Dai; Q Meng; Jing Wu; Z Z Ao; H Q Jiang; Yong Yang; L H Qu; C B Deng; Wei Wei; Yongsheng Li; Q I Wang; Jie Yang Journal: Front Pediatr Date: 2020-04-02 Impact factor: 3.418